Screener
Eli Lilly LLY Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Eli Lilly’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 2:40 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000059478-26-000081
FAQ
- What is Eli Lilly's other non-current liabilities?
- Eli Lilly (LLY) reported other non-current liabilities of $7.34B in Q2 2026.
- How has Eli Lilly's other non-current liabilities changed year-over-year?
- Eli Lilly's other non-current liabilities increased by 213.2% year-over-year, from $2.34B to $7.34B.
- What is the long-term trend for Eli Lilly's other non-current liabilities?
- Over 5 years (2020 to 2025), Eli Lilly's other non-current liabilities has grown at a 18.4% compound annual growth rate (CAGR), from $1.71B to $3.97B.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Eli Lilly's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude